Gastroretentive carbidopa/levodopa, DM‐1992, for the treatment of advanced Parkinson's disease

E-ISSN： 1531-8257|30|9|1222-1228

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.9, 2015-08, pp. : 1222-1228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa––carbidopa intestinal gel for treatment of advanced Parkinson’’s disease

By Fernandez H.H. Odin P.

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 907-919

Informa Healthcare

Access to resources Recommend Favorite

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 500-509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suicide in Parkinson's Disease Patients Treated With Levodopa‐Carbidopa Intestinal Gel

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1434-1435

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off

By Findley Leslie J Lees Andrew Apajasalo Marjo Pitkänen Anna Turunen Heidi

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1005-1014

Informa Healthcare

Access to resources Recommend Favorite

Reply to letter: Suicide in Parkinson's disease patients treated with levodopa‐carbidopa Intestinal Gel

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1435-1436

John Wiley & Sons Inc

Access to resources Recommend Favorite